NEW YORK (Reuters Health) – Bevacizumab improved visual acuity and
Bevacizumab an Option for Diabetic Macular Edema
NEW YORK (Reuters Health) – Bevacizumab improved visual acuity and
EU Investigating Teva for Blocking Rivals to Multiple Sclerosis Drug
BRUSSELS (Reuters) – Israeli drugmaker Teva is being investigated by
Incurable skin rash: those Who suffer from psoriasis, is often excluded
Psoriasis is a very visible skin disease. Many of those